Accession Number: | 0001127602-19-029139 |
Date: | 2019-09-25 |
Issuer: | APELLIS PHARMACEUTICALS, INC. (APLS) |
Original Submission Date: |
DESCHATELETS PASCAL
C/O APELLIS PHARMACEUTICALS, INC
6400 WESTWIND WAY, SUITE A
CRESTWOOD, KY 40014
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-25 | S | 20,531 | d | $25.24 | 882,753 | direct | ||
COMMON STOCK | 2019-09-25 | S | 1,010 | d | $25.64 | 881,743 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | sale originated from established 10b5-1 trading plan. |
f2 | average sale price within $1. min $24.58-max $25.56 |
f3 | average sale price within $1. min $25.58-max $25.82 |